Amphastar Pharmaceuticals (AMPH) Asset Utilization Ratio (2014 - 2026)

Amphastar Pharmaceuticals has reported Asset Utilization Ratio for 13 years, with the latest figure at 0.43 in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio fell 3.46% year-over-year to 0.43 in Q2 2026; TTM through Jun 2026 was 0.43, a 3.46% decrease from a year earlier, with the FY2025 full-year figure at 0.45, down 5.22% from the prior year.
• Asset Utilization Ratio was 0.43 for Q2 2026 at Amphastar Pharmaceuticals, down from 0.44 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.68 in Q1 2023, with the low at 0.41 in Q3 2023.
• Average Asset Utilization Ratio over 5 years is 0.51, with a median of 0.46 recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio plunged 38.46% in 2023, then rose 15.82% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.68 in 2022, then plunged by 37.97% to 0.42 in 2023, then grew by 11.22% to 0.47 in 2024, then dropped by 6.81% to 0.44 in 2025, then fell by 1.47% to 0.43 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.43 (Q2 2026), 0.44 (Q1 2026), and 0.44 (Q4 2025), per Business Quant data.